RS 09

CAT: 0804-HY-P1439-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-P1439-01Size:1 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
RS 09 is an LPS (HY-D1056) peptide mimic and TLR4 agonist. RS 09 can bind to TLR-4 and activate NF-κB. RS 09 can function as an adjuvant in vivo, enhancing the antigen-specific immune response[1].
CAS Number
[1449566-36-2]
UNSPSC
12352209
Target
NF-κB; Toll-like Receptor (TLR)
Type
Peptides
Related Pathways
Immunology/Inflammation; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rs-09.html
Purity
99.88
Solubility
H2O : 100 mg/mL (ultrasonic)
Smiles
OC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H]1CCCN1C([C@@H]2CCCN2C([C@@H](N)C)=O)=O)=O)CC3=CNC=N3)=O)C)=O)CC(C)C)=O)CO)=O
Molecular Formula
C31H49N9O9
Molecular Weight
691.78
References & Citations
[1]Shanmugam A, et al. Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PLoS One. 2012;7 (2) :e30839.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
TLR4
Citation 01
ACS Chem Neurosci. 2025 Mar 5;16 (5) :968-980.|Bioact Mater. 2022 Nov 9:23:69-79.|Biochim Biophys Acta Mol Basis Dis. 2025 Feb 8;1871 (3) :167710.|Cell Signal. 2025 Sep 18:136:112140.|Hepatology. 2025 Nov 7.|J Ethnopharmacol. 2025 Oct 15;355 (Pt B) :120749.|Mol Cell Biol. 2025 Nov 25:1-12.|Mol Neurobiol. 2025 May;62 (5) :6070-6087.|Neurochem Int. 2025 Feb 4:105940.|NPJ Parkinsons Dis. 2025 Nov 28;11 (1) :342.|Phytomedicine. 2024 Dec 3:136:156314.|Clin Exp Hypertens. 2025 Dec;47 (1) :2486829.|Int Immunopharmacol. 2024 May 9:134:112188.|J Adv Res. 2024 Nov 14:S2090-1232 (24) 00536-8.|Phytomedicine. 2022 Oct:105:154360.|Placenta. 2025 Jan 3:160:89-99.

Popular Products